Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?

被引：8
|
作者：
Dapra, Valentina [1 ,2 ]
Airoldi, Marco [1 ,2 ]
Bartolini, Michela [1 ,2 ]
Fazio, Roberta [1 ,2 ]
Mondello, Giuseppe [2 ]
Tronconi, Maria Chiara [2 ]
Prete, Maria Giuseppina [2 ]
D'Agostino, Giuseppe [3 ]
Foppa, Caterina [1 ,4 ]
Spinelli, Antonino [1 ,4 ]
Puccini, Alberto [2 ]
Santoro, Armando [1 ,2 ]
机构：
[1] Humanitas Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Italy
[2] IRCCS Humanitas Res Hosp, Humanitas Canc Ctr, Med Oncol & Hematol Unit, I-20089 Rozzano, Italy
[3] IRCCS Humanitas Res Hosp, Radiotherapy & Radiosurg Dept, I-20089 Rozzano, Italy
[4] IRCCS Humanitas Res Hosp, Div Colon & Rectal Surg, I-20089 Rozzano, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 15期
关键词：
locally advanced rectal cancer; total neoadjuvant therapy; rectal cancer; nonoperative management; ct-DNA; MMR-deficient tumor; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; PREOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; OPEN-LABEL; POSTOPERATIVE CHEMORADIOTHERAPY; FOLLOW-UP;
D O I：
10.3390/ijms241512159
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The therapeutic landscape in locally advanced rectal cancer (LARC) has undergone a significant paradigm shift in recent years with the rising adoption of total neoadjuvant treatment (TNT). This comprehensive approach entails administering chemotherapy and radiation therapy before surgery, followed by optional adjuvant chemotherapy. To establish and deliver the optimal tailored treatment regimen to the patient, it is crucial to foster collaboration among a multidisciplinary team comprising healthcare professionals from various specialties, including medical oncology, radiation oncology, surgical oncology, radiology, and pathology. This review aims to provide insights into the current state of TNT for LARC and new emerging strategies to identify potential directions for future research and clinical practice, such as circulating tumor-DNA, immunotherapy in mismatch-repair-deficient tumors, and nonoperative management.
引用
收藏
页数：16
相关论文
共 50 条
  • [31] Locally Advanced Rectal Cancer: New Neoadjuvant Strategies and Total Neoadjuvant Therapy
    Hofheinz, Ralf-Dieter
    ZENTRALBLATT FUR CHIRURGIE, 2024, 149 (01): : 56 - 66
  • [32] NAR Score validation in TNT (Total Neoadjuvant treatment) for locally advanced rectal cancer
    PERROT ROSENBERG, I. D.
    Solis Campos, J. A.
    Lazcano Alvarez, G.
    Veillon Contreras, G.
    Tudela Staub, B.
    Olivares Gonzalez, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1117 - S1117
  • [33] Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia
    Tuta, Mojca
    Boc, Nina
    Brecelj, Erik
    Omejc, Mirko
    Anderluh, Franc
    Ermenc, Ajra Secerov
    Peressutti, Ana Jeromen
    Oblak, Irena
    Krebs, Bojan
    Velenik, Vaneja
    RADIOLOGY AND ONCOLOGY, 2019, 53 (04) : 465 - 472
  • [34] Prolonged anticoagulant treatment in patients with cancer: Where do we stand?
    Napolitano, Mariasanta
    Siragusa, Sergio
    THROMBOSIS RESEARCH, 2017, 158 : 152 - 153
  • [35] Chemoimmunotherapy in the context of total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer
    Shamseddine, A.
    Turfa, R.
    Elias, C.
    Kattan, J.
    Mukherji, D.
    Temraz, S.
    Alqasem, K.
    Amarin, R.
    Al Awabdeh, T.
    Deeba, S.
    Mohamad, I.
    Daoud, F.
    Al Masri, M.
    Dabous, A.
    Hushki, A.
    Jaber, O.
    Charafeddine, M.
    Al Darazi, M.
    Zeidan, Y.
    Geara, F.
    ANNALS OF ONCOLOGY, 2022, 33 : S339 - S339
  • [36] The Impact on Survival of Neoadjuvant Treatment Interruptions in Locally Advanced Rectal Cancer Patients
    Liscu, Horia-Dan
    Antone-Iordache, Ionut-Lucian
    Atasiei, Dimitrie-Ionut
    Anghel, Ioana Valentina
    Ilie, Andreea-Teodora
    Emamgholivand, Taraneh
    Ionescu, Andreea-Iuliana
    Sandru, Florica
    Pavel, Christopher
    Ultimescu, Flavia
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (03):
  • [37] ADVANCED OVARIAN-CANCER - WHERE DO WE STAND AND WHERE DO WE GO - PREFACE
    LUND, B
    NEIJT, J
    ANNALS OF ONCOLOGY, 1993, 4 : 1 - 1
  • [38] Chemotherapy for advanced gastric cancer: Where do we stand?
    Fuchs, CS
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (11) : 3299 - 3300
  • [39] Current Trends in the Treatment of Locally Advanced Rectal Cancer: Where We Are and How We Got Here
    Shulman, Rebecca M.
    Meyer, Joshua E.
    CURRENT COLORECTAL CANCER REPORTS, 2021, 17 (06) : 88 - 102
  • [40] Reply to: Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?
    Scott, Aaron J.
    Kennedy, Erin B.
    Gholami, Sepideh
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08)
12345